Bone marrow impairment during early [177Lu]PSMA-617 radioligand therapy: Haematotoxicity or tumour progression?

Por Felix Kind, Kerstin Michalski, Elham Yousefzadeh-Nowshahr, Philipp T. Meyer, Michael Mix, Juri Ruf
Publicado em 2022-04-01

Fully Automatic Danger Zone Determination for SBRT in NSCLC

Por Tobias Fechter, Jose Dolz, Alin Chirindel, Matthias Schlachter, Montserrat Carles, Sonja Adebahr, Michael Mix, Ursula Nestle
Publicado no Journal of Radiation Oncology Informatics (2015)

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET

Por Nicole Wiedenmann, Hatice Bunea, Hans C. Rischke, Andrei Bunea, Liette Majerus, Lars Bielak, Alexey Protopopov, Ute Ludwig, Martin Büchert, Christian Stoykow, Nils H. Nicolay, Wolfgang A. Weber, Michael Mix, Philipp T. Meyer, Jürgen Hennig, Michael Bock, Anca L. Grosu
Publicado em 2018-08-01

Efficacy and Toxicity of Different Chemotherapy Protocols for Concurrent Chemoradiation in Non-Small Cell Lung Cancer—A Secondary Analysis of the PET Plan Trial

Por Eleni Gkika, Stefan Lenz, Tanja Schimek-Jasch, Cornelius F. Waller, Stephanie Kremp, Andrea Schaefer-Schuler, Michael Mix, Andreas Küsters, Marco Tosch, Thomas Hehr, Susanne Martina Eschmann, Yves-Pierre Bultel, Peter Hass, Jochen Fleckenstein, Alexander Henry Thieme, Marcus Stockinger, Karin Dieckmann, Matthias Miederer, Gabriele Holl, Hans Christian Rischke, Sonja Adebahr, Jochem König, Harald Binder, Anca-Ligia Grosu, Ursula Nestle
Publicado em 2020-11-01